A 65-year-old woman with highly symptomatic (New York Heart Association [NYHA] class III/IV), non-ischaemic cardiomyopathy with severe systolic left ventricular dysfunction (left ventricular ejection fraction [LVEF] of 18%), and not fulfilling the criteria for cardiac resynchronisation therapy (CRT) underwent an implantation of a cardiac contractility modulator (CCM) (Model Optimizer IVs; Impulse Dynamics, Orangeburg, NY, USA) in October 2015. The device was placed typically in the right subclavian position. Three intracardiac leads were inserted via right axillary vein: one to the right atrium and two to the right ventricle (in low and medial septal positions).

